We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment.
- Authors
Yamada, Yusei; Fukaura‐Nishizawa, Madoka; Nishiyama, Asami; Ishii, Akira; Kawata, Tatsuya; Shirakawa, Aina; Tanaka, Mayuko; Kondo, Yuki; Takeo, Toru; Nakagata, Naomi; Miwa, Toru; Takeda, Hiroki; Orita, Yorihisa; Motoyama, Keiichi; Higashi, Taishi; Arima, Hidetoshi; Seki, Takahiro; Kurauchi, Yuki; Katsuki, Hiroshi; Higaki, Katsumi
- Abstract
Background: Niemann–Pick disease type C (NPC) is a fatal neurodegenerative disorder caused by abnormal intracellular cholesterol trafficking. Cyclodextrins (CDs), the most promising therapeutic candidates for NPC, but with concerns about ototoxicity, are cyclic oligosaccharides with dual functions of unesterified cholesterol (UC) shuttle and sink that catalytically enhance the bidirectional flux and net efflux of UC, respectively, between the cell membrane and the extracellular acceptors. However, the properties of CDs that regulate these functions and how they could be used to improve treatments for NPC are unclear. Methods: We estimated CD–UC complexation for nine CD derivatives derived from native α‐, β‐, and γ‐CD with different cavity sizes, using solubility and molecular docking analyses. The stoichiometry and complexation ability of the resulting complexes were investigated in relation to the therapeutic effectiveness and toxicity of each CD derivative in NPC experimental models. Findings: We found that shuttle and sink activities of CDs are dependent on cavity size‐dependent stoichiometry and substituent‐associated stability of CD–UC complexation. The ability of CD derivatives to form 1:1 and 2:1 complexes with UC were correlated with their ability to normalize intracellular cholesterol trafficking serving as shuttle and with their cytotoxicity associated with cellular UC efflux acting as sink, respectively, in NPC model cells. Notably, the ability of CD derivatives to form an inclusion complex with UC was responsible for not only efficacy but ototoxicity, while a representative derivative without this ability negligibly affected auditory function, underscoring its preventability. Conclusions: Our findings highlight the importance of strategies for optimizing the molecular structure of CDs to overcome this functional dilemma in the treatment of NPC.
- Subjects
CYCLODEXTRIN derivatives; NIEMANN-Pick diseases; MOLECULAR structure; CHOLESTEROL; MOLECULAR docking; EFFLUX (Microbiology)
- Publication
Clinical & Translational Medicine, 2023, Vol 13, Issue 8, p1
- ISSN
2001-1326
- Publication type
Article
- DOI
10.1002/ctm2.1350